| Released | Contributor | Author | Title | Pages | Price |
| 5-Dec-2009 | PriceTarget Research, Inc. |
N/A
| Drug Intelligence Monitor: overall outlook NEUTRAL - 25 new Leaders; 25 new Laggards. | 65 |
$20 |
| 4-Dec-2009 | Pechala's Reports | Frantisek Pechala | JAVELIN PHARMACEUTICALS INC (JAV=US) 12-months forecast | 1 |
$15 |
| 4-Dec-2009 | Pechala's Reports | Lubomir Pechala | JAVELIN PHARMACEUTICALS INC (JAV=US) 2-weeks forecast | 1 |
$10 |
| 4-Dec-2009 | Pechala's Reports | Lubomir Pechala | JAVELIN PHARMACEUTICALS INC (JAV=US) - REPORT FOR ACTIVE TRADERS | 4 |
$25 |
| 3-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for MEDICAL SUPPLIES | 18 |
$49 |
| 3-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ADLR , BIOD , INFI , JAV , KERX , MBRK , NGSX , SNTA -- DRUGS | 3 |
$4 |
| 3-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: JAVELIN PHARMA -- JAV | 1 |
$4 |
| 1-Dec-2009 | EconomicInvestor |
N/A
| "The Economy Matters" Report for JAV: the economy's impact on JAV's price and risk, featuring the powerful EconomicInvestor Star Rating | 6 |
$15 |
| 30-Nov-2009 | Zacks Investment Research Inc. |
N/A
| JAVELIN PHARMA (JAV) Zacks Company Snapshot | 1 |
$10 |
| 30-Nov-2009 | Reuters Investment Profile |
N/A
| Javelin Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
0.22% Nasdaq 
Research Reports
